Serial Number
90763393
Owner
Novotech Health Holdings Pte LtdAttorney
Matthew P. Hintz, Esq.Filing Date
Jun 9, 2021
Serial #90763393 Trademark
Serial Number: 90763393 • Registration: 7282788
Trademark Classes
Owner Contact Info
83 Clemenceau Avenue #11-01 UE Square
Singapore 239920 , SG
Entity Type: 99
Legal Representation
Trademark Details
Filing Date
June 9, 2021
Registration Date
January 23, 2024
Published for Opposition
November 7, 2023
Goods & Services
Scientific research in the nature of conducting clinical trials for others; Scientific research in the nature of conducting clinical trials for others in the field of pharmaceuticals, biotechnology and other related industries; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Scientific research in the field of clinical trials; Scientific research for medical purposes, namely, medical research; Scientific research in the nature of preparation of statistics for scientific research; Scientific research in the nature of preparation of biostatistics for scientific research in the fields of pharmaceuticals, biotechnology and other related industries; Provision of medical and scientific research information and data in the field of pharmaceuticals, biotechnology and related industries technical information in the field of interior design; Database design and development services to process data collected from clinical trials; Medical research services, namely, medical monitoring services for research in the fields of pharmaceuticals, biotechnology and other related industries; Quality audits for clinical trials; Preparation of reports on outcome of the scientific experiments and applications to regulators relating to of clinical trials; Providing a web site featuring technology that enables exchange of information and data exchange between scientists, manufacturers and health authorities relating to pharmaceutical and biotechnology quality standards; Technical writing of clinical report forms which are required by clinical trial drug protocols